Discover 1,359 paid clinical trials in Athens, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,359
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
for
Schizophrenia
Location: Decatur GA, Atlanta GA, West Chester OH,
Sponsor: MapLight Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07459647
Phase2, Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
for
Schizophrenia
Location: Decatur GA, Atlanta GA, Maitland FL, Flowood MS,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18 - 65
Code: NCT07114874
Phase3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Decatur GA, Anderson SC, Atlanta GA, Spartanburg SC,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase3, Recruiting
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks
for
Diabetic Neuropathy
Location: Roswell GA
Sponsor: Endocrine Research Solutions
Sex: All
Age: 18 - 70+
Code: NCT06452914
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: Rosewell GA, Atlanta GA, Asheville NC, Chattanooga TN,
Sponsor: Insulet Corporation
Sex: All
Age: 18 - 70+
Code: NCT07521475
Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Decatur GA, Atlanta GA, Jacksonville FL, Orlando FL,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase2, Recruiting
New
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
for
Influenza, Human
Location: Decatur GA, Atlanta GA, Anderson SC, Riverdale GA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 65+
Code: NCT07805707
Phase3, Recruiting
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
for
Schizophrenia, Bipolar I Disorder
Location: Decatur GA, Dothan AL, Cincinnati OH, West Chester OH,
Sponsor: Alkermes, Inc.
Sex: All
Age: 10 - 17
Code: NCT05303064
Phase3, Recruiting
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
for
Schizophrenia
Location: Decatur GA, Atlanta GA, Gaithersburg MD, Little Rock AR,
Sponsor: Reviva Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT05184335
Phase3, Recruiting
Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection
for
HIV/AIDS
Location: Decatur GA, Orlando FL, Saint Louis MO,
Sponsor: Frontier Biotechnologies Inc.
Sex: All
Age: 18+
Code: NCT04560569
Phase2, Recruiting
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
for
Schizophrenia, Bipolar I Disorder
Location: Decatur GA, Atlanta GA, Dothan AL, Kinston NC,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 12 - 17
Code: NCT05648591
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
for
Osteoarthritis, Overweight or Obesity
Location: Decatur GA, Jacksonville FL, Louisville KY, Mobile AL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07353931
Phase3, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: Seneca SC, Easley SC, Greenville SC, Augusta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)